Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.66 |
| ▸ | MAPT | P10636 | 2/20 | 0.66 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.66 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.66 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.50 |
| ▸ | CPA1 | P15085 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | SERPINH1 | P50454 | 2/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 5/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4725978 | 1.00 | MAPK1 (0.66) | MAPK1MAPTNPSR1TDP1KDM4E | |
| SCHEMBL7254921 | 0.84 | NPSR1 (0.50) | MAPK1MAPTNPSR1TDP1KDM4E | |
| SCHEMBL28551820 | 0.83 | MAPK1 (0.65) | MAPK1MAPTNPSR1TDP1KDM4E | |
| SCHEMBL7258520 | 0.80 | MAPT (0.54) | MAPK1MAPTNPSR1TDP1KDM4E | |
| SCHEMBL7606406 | 0.80 | MAPT (0.47) | MAPK1MAPTNPSR1TDP1KDM4E | |
| SCHEMBL7606395 | 0.79 | MAPT (0.52) | MAPK1MAPTNPSR1TDP1KDM4E | |
| SCHEMBL9202581 | 0.79 | NPC1 (0.56) | MAPK1MAPTNPSR1TDP1KDM4E | |
| SCHEMBL7254995 | 0.78 | MAPT (0.45) | MAPK1MAPTNPSR1TDP1KDM4E | |
| SCHEMBL7255304 | 0.78 | MAPK1 (0.51) | MAPK1MAPTNPSR1TDP1KDM4E | |
| SCHEMBL29045032 | 0.78 | MAPT (0.66) | MAPK1MAPTNPSR1TDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11072713-B2 | Bugphobic and icephobic compositions with fluid additives | HRL LABORATORIES, LLC (US) | 2021-07-27 | — | — | US | claimed |
| US-20190023910-A1 | BUGPHOBIC AND ICEPHOBIC COMPOSITIONS WITH FLUID ADDITIVES | HRL LABORATORIES, LLC | 2019-01-24 | — | — | US | claimed |
| US-5635371-A | Chemical method for selective modification of the N- and/or C-terminal amino acid α-carbon reactive group of a recombinant polypeptide or a portion thereof | BIONEBRASKA, INC. (US) | 1997-06-03 | — | — | US | claimed |
| US-11859098-B2 | Formulas and methods for making shelf-stable antimicrobial biphasic polymers | HRL LABORATORIES, LLC (US) | 2024-01-02 | — | — | US | disclosed |
| EP-3645655-B1 | POLYMER LIQUID COMPOSITES FOR IMPROVED ANTI-FOULING PERFORMANCE | HRL LAB LLC (US) | 2023-09-27 | — | — | EP | disclosed |
| EP-4165112-A1 | FAST-ACTING ANTIMICROBIAL SURFACES, AND METHODS OF MAKING AND USING THE SAME | HRL LABORATORIES, LLC (US) | 2023-04-19 | — | — | EP | disclosed |
| US-20230097289-A1 | SENSORS FOR ANTIMICROBIAL BIPHASIC POLYMERS, AND SYSTEMS AND METHODS INCORPORATING THE SAME | HRL LABORATORIES, LLC | 2023-03-30 | — | — | US | disclosed |
| US-20230090180-A1 | FORMULAS AND METHODS FOR MAKING SHELF-STABLE ANTIMICROBIAL BIPHASIC POLYMERS | HRL LABORATORIES, LLC | 2023-03-23 | — | — | US | disclosed |
| US-20220225608-A1 | FAST-ACTING ANTIMICROBIAL SURFACES, AND METHODS OF MAKING AND USING THE SAME | HRL LABORATORIES, LLC | 2022-07-21 | — | — | US | disclosed |
| US-11369109-B2 | Fast-acting antimicrobial surfaces, and methods of making and using the same | HRL LABORATORIES, LLC (US) | 2022-06-28 | — | — | US | disclosed |
| WO-2021252007-A1 | FAST-ACTING ANTIMICROBIAL SURFACES, AND METHODS OF MAKING AND USING THE SAME | HRL LABORATORIES, LLC (US) | 2021-12-16 | — | — | WO | disclosed |
| US-20040006091-A1 | Therapeutic agents useful for treating or preventing pain | PURDUE PHARMA L.P. | 2004-01-08 | — | — | US | disclosed |
| WO-2003066595-A2 | 2 - PIPERAZINE - PYRIDINES USEFUL FOR TREATING PAIN | EURO-CELTIQUE S.A. (LU) | 2003-08-14 | — | — | WO | disclosed |
| EP-0651761-B1 | METHOD FOR MODIFICATION OF RECOMBINANT POLYPEPTIDES | BIONEBRASKA INC (US) | 2002-10-09 | — | — | EP | disclosed |
| EP-1170300-A1 | Method for modification of recombinant polypeptides | BIONEBRASKA, INC. (US) | 2002-01-09 | — | — | EP | disclosed |
| US-5656456-A | Chemical method for selective modification of the N- and/or C-terminal amino acid α-carbon reactive group of a recombinant polypeptide or a portion thereof | BIONEBRASKA, INC. (US) | 1997-08-12 | — | — | US | disclosed |
| US-5635371-A | Chemical method for selective modification of the N- and/or C-terminal amino acid α-carbon reactive group of a recombinant polypeptide or a portion thereof | BIONEBRASKA, INC. (US) | 1997-06-03 | — | — | US | disclosed |
| US-5633364-A | N4 -substituted 2'-deoxycytidine compounds, oligonucleotides including N4 -labeled 2'-deoxycytidines, and a process for making oligonucleotides with N-modified 2'-deoxycytidines | AMOCO CORPORATION (US) | 1997-05-27 | — | — | US | disclosed |
| US-5405950-A | N4 -substituted cytidines and process for incorporation into an oligonucleotides | AMOCO CORPORATION (US) | 1995-04-11 | — | — | US | disclosed |
| EP-0222889-B1 | CYTIDINE ANALOGS | AMOCO CORP (US) | 1993-10-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220225608-A1 | FAST-ACTING ANTIMICROBIAL SURFACES, AND METHODS OF MAKING AND USING THE SAME | ACE2, ACE, BST2 | MAPK1 3588/4885MAPT 2596/4885NPSR1 3715/4885 |
| US-11072713-B2 | Bugphobic and icephobic compositions with fluid additives | FUS, IGF2BP1, IGF2BP3 | MAPK1 2725/4885MAPT 211/4885NPSR1 3140/4885 |
| US-20040006091-A1 | Therapeutic agents useful for treating or preventing pain | OPRK1, OPRL1, OPRD1 | MAPK1 3114/4885MAPT 3966/4885NPSR1 76/4885 |
| US-11369109-B2 | Fast-acting antimicrobial surfaces, and methods of making and using the same | ACE2, ACE, BST2 | MAPK1 3594/4885MAPT 2632/4885NPSR1 3761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.